1Swedo, SE, Leonard, HL, Garvey, M, Mittleman, B, Allen, AJ, Perlmutter, S, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998; 155: 264–71.
2Swedo, SE, Leckman, JF, Rose, NR. From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS (Pediatric Acute-onset Neuropsychiatric Syndrome). Pediatr Ther 2012; 2: 113.
3Frankovich, J, Swedo, S, Murphy, T, Dale, RC, Agalliu, , Danes, M, et al. Clinical management of pediatric acute-onset neuropsychiatric syndrome: Part II—use of immunomodulatory therapies. J Child Adolesc Psychopharmacol 2017; 27: 574–93.
4Sigra, S, Hesselmark, E, Bejerot, S. Treatment of PANDAS and PANS: a systematic review. Neurosci Biobehav Rev 2018; 86: 51–65.
5Frankovich, J, Thienemann, M, Pearlstein, J, Crable, A, Brown, K, Chang, K. Multidisciplinary clinic dedicated to treating youth with pediatric acute-onset neuropsychiatric syndrome: presenting characteristics of the first 47 consecutive patients. J Child Adolesc Psychopharmacol 2015; 25: 38–47.
6Brown, K, Farmer, C, Farhadian, B, Hernandez, J, Thienemann, M, Frankovich, J. Pediatric acute-onset neuropsychiatric syndrome response to oral corticosteroid bursts: an observational study of patients in an academic community-based PANS clinic. J Child Adolesc Psychopharmacol 2017; 27: 629–39.
7Brown, KD, Farmer, C, Freeman, GM, Spartz, EJ, Farhadian, B, Thienemann, M, et al. Effect of early and prophylactic nonsteroidal anti-inflammatory drugs on flare duration in pediatric acute-onset neuropsychiatric syndrome: an observational study of patients followed by an academic community-based pediatric acute-onset neuropsychiatric syndrome clinic. J Child Adolesc Psychopharmacol 2017; 27: 619–28.
8Chang, K, Frankovich, J, Cooperstock, M, Cunningham, MW, Latimer, ME, Murphy, TK, et al. Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): Recommendations from the 2013 PANS consensus conference. J Child Adolesc Psychopharmacol 2015; 25: 3–13.
9Gilbert, DL, Mink, JW, Singer, HS. A Pediatric neurology perspective on pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection and pediatric acute-onset neuropsychiatric syndrome. J Pediatr 2018; 199: 243–51.
11Cox, CJ, Zuccolo, AJ, Edwards, EV, Mascaro-Blanco, A, Alvarez, K, Stoner, J, et al. Antineuronal antibodies in a heterogeneous group of youth and young adults with tics and obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 2015; 25: 76–85.
12Kirvan, CA, Swedo, SE, Heuser, JS, Cunningham, MW. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nature Med 2003; 9: 914–20.
13Kirvan, CA, Cox, CJ, Swedo, SE, Cunningham, MW. Tubulin is a neuronal target of autoantibodies in Sydenham's chorea. J Immunol 2007; 178: 7412–21.
14Kirvan, CA, Swedo, SE, Snider, LA, Cunningham, MW. Antibody-mediated neuronal cell signaling in behavior and movement disorders. J Neuroimmunol 2006; 179: 173–9.
15Singer, HS, Mascaro-Blanco, A, Alvarez, K, et al. Neuronal antibody biomarkers for Sydenham's chorea identify a new group of children with chronic recurrent episodic acute exacerbations of tic and obsessive compulsive symptoms following a streptococcal infection. PLoS One 2015; 10: e0120499.
16Hesselmark, E, Bejerot, S. Biomarkers for diagnosis of pediatric acute neuropsychiatric syndrome (PANS) - sensitivity and specificity of the Cunningham Panel. J Neuroimmunol 2017; 312: 31–7.
17Sheehan, DV, Lecrubier, Y, Sheehan, KH, Amorim, P, Janavs, J, Weiller, E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 (suppl 20): 22–33.
18Sheehan, DV, Sheehan, KH, Shytle, RD, Janavs, J, Bannon, Y, Rogers, JE, et al. Reliability and validity of the mini international neuropsychiatric interview for children and adolescents (MINI-KID). J Clin Psychiatry 2010; 71: 313–26.
19Goodman, WK, Price, LH, Rasmussen, SA, Mazure, C, Fleischmann, RL, Hill, CL, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989; 46: 1006–11.
20Guy, W. ECDEU Assessment Manual for Psychopharmacology —Revised (DHEW Publ No ADM 76-338). US Department of Health, Education, and Welfare, 1976.
21Wechsler, D. Wechsler Adult Intelligence Scale—Fourth Edition Administration and Scoring Manual. Pearson, 2008.
22Wechsler, D. Wechsler Intelligence Scale for Children Third Edition Manual. Psychological Corporation, 1991.
23Murphy, TK, Storch, EA, Lewin, AB, Edge, PJ, Goodman, WK. Clinical factors associated with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. J Pediatr 2012; 160: 314–9.
24Murphy, TK, Patel, PD, McGuire, JF, Kennel, A, Mutch, PJ, Parker-Athill, EC, et al. Characterization of the pediatric acute-onset neuropsychiatric syndrome phenotype. J Child Adolesc Psychopharmacol 2014; 25: 14–25.
25Bejerot, S, Hesselmark, E, Humble, MB. Abstract # 1786 The PsychoNeuroInflammatory related Signs and Severity Inventory (PNISSI). Brain Behav Immun 2016; 57 (suppl): e23.